Dr. Burton E. Sobel

Burton E. Sobel , M.D. , was appointed as a director by the Board in February 2000 to fill a new seat on the Board.If elected at the Annual Meeting , each of the nominees would serve until the 2004 annual meeting and until his successor is elected and has qualified , or until such director's earlier death , resignation or removal.

Directors are elected by a plurality of the votes present in person or represented by proxy and entitled to vote at the Annual Meeting.Shares represented by executed proxies will be voted , if authority to do so is not withheld , for the election of the three nominees named below.In the event that any of the nominees should be unavailable for election as a result of an unexpected occurrence , such shares will be voted for the election of such substitute nominee as management may propose.All three nominees for election have agreed to serve if elected , and management has no reason to believe that any of the nominees will be unable to serve.

Biographical information for each person nominated as a director , and for each person whose term of office as a director will continue after the Annual Meeting , is set forth below.

Burton E. Sobel , M.D. , was appointed as a director by the Board in February 2000 to fill a new seat on the Board.If elected at the Annual Meeting , each of the nominees would serve until the 2004 annual meeting and until his successor is elected and has qualified , or until such director's earlier death , resignation or removal.Directors are elected by a plurality of the votes present in person or represented by proxy and entitled to vote at the Annual Meeting.Shares represented by executed proxies will be voted , if authority to do so is not withheld , for the election of the three nominees named below.In the event that any of the nominees should be unavailable for election as a result of an unexpected occurrence , such shares will be voted for the election of such substitute nominee as management may propose.All three nominees for election have agreed to serve if elected , and management has no reason to believe that any of the nominees will be unable to serve.Biographical information for each person nominated as a director , and for each person whose term of office as a director will continue after the Annual Meeting , is set forth below.NOMINEES FOR ELECTION FOR A THREE-YEAR TERM EXPIRING AT THE 2004 ANNUAL MEETING
...
BURTON E. SOBEL , M.D..Dr. Sobel , age 63 , has served as a director of Corvas since February 2000.Dr. Sobel is Physician-in-Chief at Fletcher Allen Health Care and E.L. Amidon Professor and Chair of the Department of Medicine at The University of Vermont College of Medicine.Dr. Sobel currently serves on the Board of Directors of Scios Inc. and has been a consultant to and served on scientific advisory boards of several pharmaceutical and biotechnology companies.

Armacost, Kirk, Rice, Sobel, Step, Sanders and Snyder have each received option grants as a Director.
...
Step (Chairman), Armacost, Kirk and Sobel.
...
Burton E. Sobel, M.D
...
(5) For Mr. Armacost, Mr. Brewer, Mr. Kirk, Dr. Rice, Dr. Sanders, Dr. Snyder, Dr. Sobel, Mr. Step, Mr. Gryska, Dr. Schreiner, Dr. Horton, Mr. Feldman and all officers and directors as a group, includes 59,166, 447,498, 19,166, 101,582, 57,499, 48,332, 59,166, 67,499, 110,581, 196,566, 72,894, 114,914, and 1,470,324 shares, respectively, issuable upon exercise of outstanding options exercisable within sixty days of March 2, 2002. (6) Includes 481,377 shares reported to be beneficially owned by RJK, L.L.C., 276,907 shares reported to be beneficially owned by Kirkfield L.L.C., and 241,716 shares reported to be beneficially owned by the R.J. Kirk Trust under Declaration of Trust dated March 29, 2000.